Viewing Study NCT01535157


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-02 @ 8:31 AM
Study NCT ID: NCT01535157
Status: TERMINATED
Last Update Posted: 2020-08-27
First Post: 2012-02-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
Sponsor: South Plains Oncology Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module